Kiora Pharma Inc Live Stock Price Today, Share Analysis and Chart

Name: Kiora Pharmaceuticals Inc: Is Infosys Ltd. worth buying?
Item: Kiora Pharmaceuticals Inc
Rating: 1.77083325
Author: Trendlyne DVM scores

about

Kiora Pharmaceuticals Inc is a clinical-stage biotechnology company developing and commercializing products for the treatment of orphan retinal diseases. As part of its development, KIO-301 is being studied for the treatment of retinitis pigmentosa, ...

2.63 0.08 (3.14%)

49.43% Gain from 52W Low

17,249

XNAS Volume

XNAS 17 Jul, 2026 5:30 PM (EDT)

Not Eligible

Expensive Valuation

13.8 / 100

Technically Neutral

57.0 / 100

1Yr Price target upside is 356%

1 analysts

Kiora Pharma Inc Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

Kiora Pharma Inc Live Stock Price Today, Share Analysis and Chart

Kiora Pharmaceuticals Inc is a clinical-stage biotechnology company developing and commercializing products for the treatment of orphan retinal diseases. As part of its development, KIO-301 is being studied for the treatment of retinitis pigmentosa, ...

49.43% Gain from 52W Low

SWOT Analysis

Kiora Pharma Inc Live Price Chart

Kiora Pharma Inc Live Price Chart